Chubb Ltd’s PTC Therapeutics PTCT Stock Holding History

Chubb Ltd’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$312K	Hold	8,180	–	–	1.04%	3
2022 Q3	$411K	Hold	8,180	–	–	1.52%	3
2022 Q2	$328K	Hold	8,180	–	–	1.32%	3
2022 Q1	$305K	Hold	8,180	–	–	0.76%	3
2021 Q4	$326K	Hold	8,180	–	–	0.72%	2
2021 Q3	$304K	Hold	8,180	–	–	100%	1
2021 Q2	$346K	Hold	8,180	–	–	1.23%	2
2021 Q1	$387K	Hold	8,180	–	–	1.1%	2
2020 Q4	$499K	Hold	8,180	–	–	0.47%	3
2020 Q3	$382K	Hold	8,180	–	–	7.47%	3
2020 Q2	$415K	Hold	8,180	–	–	1.47%	3
2020 Q1	$365K	Hold	8,180	–	–	1.8%	2
2019 Q4	$393K	Hold	8,180	–	–	1.68%	2
2019 Q3	$277K	Hold	8,180	–	–	1.29%	3
2019 Q2	$368K	Hold	8,180	–	–	1.82%	3
2019 Q1	$308K	Hold	8,180	–	–	0.21%	11
2018 Q4	$281K	Hold	8,180	–	–	0.2%	11
2018 Q3	$384K	Hold	8,180	–	–	0.25%	11
2018 Q2	$276K	Hold	8,180	–	–	0.12%	19
2018 Q1	$221K	Buy	+8,180	New	+$207K	0.1%	17

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Chubb Ltd's PTCT Position: Q4 2022 in Review

Chubb Ltd held its PTC Therapeutics (PTCT) position steady in Q4 2022 at 8,180 shares worth $312K. The position accounts for 1.04% of the portfolio, ranked #3.

Chubb Ltd first reported a position in PTCT in Q1 2018 and has held it in 20 quarters since. The position peaked at $499K in Q4 2020. 202 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

Chubb Ltd held 8,180 shares of PTC Therapeutics worth $312K as of Q4 2022.
Chubb Ltd left its PTC Therapeutics share count unchanged in Q4 2022.
PTC Therapeutics made up 1.04% of Chubb Ltd's portfolio in Q4 2022, its #3 holding.
Chubb Ltd first reported a position in PTC Therapeutics in Q1 2018 and has held it in 20 quarters since.
Chubb Ltd's PTC Therapeutics position peaked at $499K in Q4 2020.
202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Chubb Ltd's 13F filing for Q4 2022, filed 3 Feb 2023.